|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Surface Oncology
| | | Phone: | (617) 714-4096 | Year Established: | 2014 | Main Contact: | Detlev Biniszkiewicz, CEO | | Other Contacts: | Vito Palombella, PhD, CSO Robert Ross, MD, CMO Nicholas Buffinger, PhD, JD, Head of Corporate Development and IP Strategy Jessica Fees, Head of Finance Pamela Holland, PhD, VP, Cancer Biology Daniel Lynch, Executive Chairman Scott Chappel, PhD, CTO Jeff Goater, CBO
| | Company Description | Surface Oncology is developing next-generation immunotherapies targeting the tumor microenvironment. Their broad attack has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. The company is committed to advancing thier diverse pipeline of immunotherapies, including their fully human CD47 antibody SRF231 and CD73 antibody programs, to bring more cures to patients who do not benefit from existing cancer treatments. | |
|
|
|
|
|